三叶式主动脉瓣主动脉根部瘤:David与生物Bentall远期结局比较
该回顾性队列纳入2005至2018年在本机构接受主动脉根部置换的876例患者中的371例三叶式主动脉瓣主动脉根部瘤患者,其中David V(DV)199例、生物Bentall-De Bono(BD)172例,经倾向性评分匹配各90例。匹配后两组院内死亡率均为1.1%,10年生存率DV 95.3%与BD 98.6%无显著差异(P=0.345),但DV的全因再手术和主动脉瓣相关再手术累积发生率显著低于BD。
要点
- 匹配后DV与BD的10年生存率无显著差异(P=0.345)。
- DV全因再手术10年累积发生率3.9%,显著低于BD的18.1%(P=0.046)。
- DV主动脉瓣相关再手术10年累积发生率1.9%,显著低于BD的15.9%(P=0.032)。
核心结论
- 对三叶式主动脉瓣主动脉根部瘤患者,DV与生物BD均可获得良好的10年生存,但保留瓣膜的DV在免于全因及主动脉瓣相关再手术方面优于生物BD。
研究设计与样本
- 单中心回顾性队列研究,2005至2018年间876例主动脉根部置换患者中纳入371例三叶式主动脉瓣主动脉根部瘤患者,DV 199例、BD 172例。
- 排除主动脉瓣狭窄、感染性心内膜炎、既往人工主动脉瓣、二叶式主动脉瓣、主动脉夹层及机械Bentall手术。
- 采用倾向性评分匹配,每组匹配90例;主要终点为全因死亡,次要终点为任何原因再手术及主动脉瓣相关原因再手术。
主要发现
- 匹配后DV与BD组院内死亡率均为1.1%(各1例)。
- 10年生存率DV为95.3%(95%CI 85.8-98.5),BD为98.6%(95%CI 90.8-99.8),P=0.345。
- 10年全因再手术累积发生率DV 3.9%(95%CI 0.7-11.8)低于BD 18.1%(95%CI 6.9-33.4),P=0.046。
- 10年主动脉瓣相关再手术累积发生率DV 1.9%(95%CI 0.1-8.8)低于BD 15.9%(95%CI 5.5-31.4),P=0.032。
- 瓣膜相关再手术原因包括主动脉瓣反流(DV 3/5 vs BD 5/10)、主动脉瓣狭窄(0/5 vs 2/10)和感染性心内膜炎(2/5 vs 3/10)。
关键数值与推荐
- 10年生存率:DV 95.3%(95%CI 85.8-98.5),BD 98.6%(95%CI 90.8-99.8),P=0.345。
- 10年全因再手术累积发生率:DV 3.9%(95%CI 0.7-11.8),BD 18.1%(95%CI 6.9-33.4),P=0.046。
- 10年主动脉瓣相关再手术累积发生率:DV 1.9%(95%CI 0.1-8.8),BD 15.9%(95%CI 5.5-31.4),P=0.032。
临床怎么用
- 对三叶式主动脉瓣主动脉根部瘤患者,DV与生物BD均可作为可选术式,二者10年生存相近。
- 若关注远期免于再手术,尤其是主动脉瓣相关再手术,DV可能较生物BD更具优势。
局限性
- 本研究为单中心回顾性分析,样本量有限,匹配后每组仅90例。
- 原文未报告匹配后两组随访时间、合并症分布及瓣膜相关再手术的具体随访完整度等信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We compared the long-term outcomes between aortic valve reimplantation [David V (DV)] and aortic valve and root replacement with biological valved conduit [Bentall-De Bono (BD)] for the patients with aortic root aneurysm with tricuspid valve. METHODS: Among 876 patients who underwent aortic root replacement in our institution between 2005 and 2018, 371 patients who underwent DV (n = 199) or BD (n = 172) for aortic root aneurysm with tricuspid valve were retrospectively reviewed. Exclusion criteria included aortic stenosis, infective endocarditis, previous prosthetic aortic valve, bicuspid aortic valve, aortic dissection and mechanical Bentall procedure. Propensity score matching was performed based on the patient characteristics, matching 90 patients in each group. The primary end point was all-cause mortality. Secondary end points were reoperation for any cause and specifically for aortic valve-related cause. RESULTS: After propensity score matching, DV and BD groups each had 1 in-hospital mortality (1.1%). Survival at 10 years was 95.3% [95% confidence interval (CI) 85.8-98.5] in DV and 98.6% (95% CI 90.8-99.8) in BD (P = 0.345). The cumulative incidences of reoperation at 10 years in DV versus BD were 3.9% (95% CI 0.7-11.8) vs 18.1% (95% CI 6.9-33.4) for any cause (P = 0.046) and 1.9% (95% CI 0.1-8.8) vs 15.9% (95% CI 5.5-31.4) for aortic valve-related causes (P = 0.032). The reasons for valve-related reoperation were aortic insufficiency (3/5 in DV vs 5/10 in BD), aortic stenosis (0/5 vs 2/10) and infective endocarditis (2/5 vs 3/10). CONCLUSIONS: Both DV and BD procedures for patients with aortic root aneurysm with tricuspid valve resulted in excellent 10-year survival. All-cause and aortic valve-related reoperations were significantly less frequent with valve-sparing root replacement, suggesting an advantage of DV over biological BD.
引用
- Yamabe T, Zhao Y, Kurlansky PA, et al. Assessment of long-term outcomes: aortic valve reimplantation versus aortic valve and root replacement with biological valved conduit in aortic root aneurysm with tricuspid valve. Eur J Cardiothorac Surg. 2021. PMID: 33230518. doi:10.1093/ejcts/ezaa389
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。